Enter assignee name

Forward Citations = 9

Loading Chart...

2 inventors (with patents filed for the assignee):

Abdelmalik Slassi (7 out of 55 patents)

Joseph Araujo (7 out of 7 patents)

7 patents: Sort by Forward Citations

1. 12378266 - Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disorders (2025-08-05),

2. 12054505 - Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disorders (2024-08-06),

3. 12054504 - 3-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the treatment of CNS disorders (2024-08-06),

4. 11597738 - Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disorders (2023-03-07),

5. 11591353 - Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disorders (2023-02-28),

6. 11453689 - 3-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the treatment of CNS disorders (2022-09-27),

7. 11427604 - Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disorders (2022-08-30),

Mindset Pharma Inc. is a biotechnology company focused on the discovery and development of next-generation psychedelic drugs for the treatment of various mental health disorders. With a team of experienced researchers and scientists, Mindset Pharma is leading the way in advancing innovative therapies that have the potential to revolutionize the field of mental health treatment. Their cutting-edge approach and commitment to scientific excellence sets them apart in the rapidly growing psychedelic medicine industry.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 13 2026

7 Patents

#185 in Toronto

#2,029 in Canada

Toronto, Canada

Mindset Pharma Inc.

Forward Citations = 9

2 inventors:

Abdelmalik Slassi (7 out of 55 patents)

Joseph Araujo (7 out of 7 patents)

Please report any incorrect information to support@idiyas.com